RandomiSed clinical trial assessing Use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer – the S.U.R.G.U.V.A.N.T. trial
暂无分享,去创建一个
D. O'Leary | H. Redmond | Jiang-huai Wang | N. Foley | P. Neary | E. O’Connell | R. Pfirrmann | M. Jinih
[1] M. Kerin,et al. The Impact of Surgical Complications on Cancer Recurrence Rates: A Literature Review , 2018, Oncology Research and Treatment.
[2] A. Bhatt,et al. Role of interleukin-6 in cancer progression and therapeutic resistance , 2016, Tumor Biology.
[3] D. O'Leary,et al. Effects of surgery on the cancer stem cell niche. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[4] D. O'Leary,et al. Influence of complications following immediate breast reconstruction on breast cancer recurrence rates , 2016, The British journal of surgery.
[5] Yinglong Zhang,et al. Interleukin-6 suppression reduces tumour self-seeding by circulating tumour cells in a human osteosarcoma nude mouse model , 2015, Oncotarget.
[6] D. O’Leary,et al. A meta‐analysis to determine the oncological implications of conversion in laparoscopic colorectal cancer surgery , 2015, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[7] L. Kirkeby,et al. High interleukin-6 mRNA expression is a predictor of relapse in colon cancer. , 2015, Anticancer Research.
[8] D. McMillan,et al. Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer , 2013, British Journal of Cancer.
[9] H. Redmond,et al. Laparotomy and laparoscopy diversely affect macrophage-associated antimicrobial activity in a murine model , 2013, BMC Immunology.
[10] D. McMillan,et al. Circulating IL-6 concentrations link tumour necrosis and systemic and local inflammatory responses in patients undergoing resection for colorectal cancer , 2013, British Journal of Cancer.
[11] H. Ripps,et al. Review: Taurine: A “very essential” amino acid , 2012, Molecular vision.
[12] D. O'Leary,et al. TLR-4 Signalling Accelerates Colon Cancer Cell Adhesion via NF-κB Mediated Transcriptional Up-Regulation of Nox-1 , 2012, PloS one.
[13] D. O'Leary,et al. Less stress, more success? Oncological implications of surgery-induced oxidative stress , 2011, Gut.
[14] T. Cotter,et al. Surgical Injury Enhances the Expression of Genes That Mediate Breast Cancer Metastasis to the Lung , 2010, Annals of surgery.
[15] H. Redmond,et al. The antiendotoxin agent taurolidine potentially reduces ischemia/reperfusion injury through its metabolite taurine. , 2010, Surgery.
[16] H. Redmond,et al. The Evolving Role of Taurolidine in Cancer Therapy , 2010, Annals of Surgical Oncology.
[17] Larry Norton,et al. Tumor Self-Seeding by Circulating Cancer Cells , 2009, Cell.
[18] J. Wind,et al. Circulating tumour cells during laparoscopic and open surgery for primary colonic cancer in portal and peripheral blood. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[19] A. Darzi,et al. Does the Presence of Circulating Tumor Cells in the Venous Drainage of Curative Colorectal Cancer Resections Determine Prognosis? A Meta-Analysis , 2008, Annals of Surgical Oncology.
[20] H. Redmond,et al. Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl‐2 family proteins , 2007, Journal of surgical oncology.
[21] J. Wang,et al. Inhibition of urokinase plasminogen activator with a novel enzyme inhibitor, wxc-340, ameliorates endotoxin and surgery-accelerated growth of murine metastases , 2007, British Journal of Cancer.
[22] H. Redmond,et al. Cell response to surgery. , 2006, Archives of surgery.
[23] T. Cotter,et al. Cancer surgery: risks and opportunities , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.
[24] J. Wang,et al. Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-κB-dependent activation of the urokinase plasminogen activator system , 2006, British Journal of Cancer.
[25] T. Cotter,et al. The Targeting of Phosphoinositide-3 Kinase Attenuates Pulmonary Metastatic Tumor Growth Following Laparotomy , 2006, Annals of surgery.
[26] H. Redmond,et al. Can surgery for cancer accelerate the progression of secondary tumors within residual minimal disease at both local and systemic levels? , 2005, The Annals of thoracic surgery.
[27] T. Cotter,et al. Phosphoinositide 3-Kinase Accelerates Postoperative Tumor Growth by Inhibiting Apoptosis and Enhancing Resistance to Chemotherapy-induced Apoptosis , 2005, Journal of Biological Chemistry.
[28] H. Redmond,et al. Surgically induced accelerated local and distant tumor growth is significantly attenuated by selective COX-2 inhibition. , 2005, The Annals of thoracic surgery.
[29] T G Cotter,et al. Excisional surgery for cancer cure: therapy at a cost. , 2003, The Lancet. Oncology.
[30] H. Redmond,et al. Endotoxin/Lipopolysaccharide Activates NF-κB and Enhances Tumor Cell Adhesion and Invasion Through a β1 Integrin-Dependent Mechanism , 2003, The Journal of Immunology.
[31] H. Redmond,et al. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery. , 2001, The Journal of surgical research.
[32] A. Lacy,et al. Acute phase response in laparoscopic and open colectomy in colon cancer , 2001, Diseases of the colon and rectum.
[33] H. Redmond,et al. Taurolidine Inhibits Tumor Cell Growth In Vitro and In Vivo , 2000, Annals of Surgical Oncology.
[34] A. Darzi,et al. Beneficial effects of taurolidine in experimental pancreatitis. , 1994, Journal of Surgical Research.
[35] I. Bedrosian,et al. Taurolidine, an analogue of the amino acid taurine, suppresses interleukin 1 and tumor necrosis factor synthesis in human peripheral blood mononuclear cells. , 1991, Cytokine.
[36] J. Wang,et al. Laparoscopic surgery protects against the oncologic adverse effects of open surgery by attenuating endothelial progenitor cell mobilization , 2005, Surgical Endoscopy.
[37] H. Redmond,et al. Endotoxin/lipopolysaccharide activates NF-kappa B and enhances tumor cell adhesion and invasion through a beta 1 integrin-dependent mechanism. , 2003, Journal of immunology.